Related Experiment Video
Updated: Jul 31, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Simulants: Synthetic Clinical Trial Data via Subject-Level Privacy-Preserving Synthesis
Mandis Beigi1, Afrah Shafquat1, Jason Mezey2
1Medidata, New York, NY, USA.
Abstract:
Clinical trials capture high-quality data for millions of patients each year, yet these data are largely unavailable for research beyond the scope of any individual trial due to a combination of regulatory, intellectual property, and patient privacy barriers. Synthetic clinical trial data that captures the analytical properties of the source data, could provide significant value for research and drug development by making insights widely available while protecting the privacy of the participants. We present a method "Simulants" for generating research-grade synthetic clinical trial data from a real data source. We compared the fidelity and privacy preservation performance of Simulants to the state-of-the-art deep learning synthesizers and found that Simulants had superior performance when applied to clinical trial data as assessed both by established metrics and when considering critical clinical features. We also demonstrate how Simulants' privacy settings may be configured to conform to specific privacy policies governing data sharing.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Data Collection by Experiments
An example of the experimental method is a public...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Blinding
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

